Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Ji

Showing results (361-370 of 365) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 365 results.
Plos One|May 5, 2012
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humansCharles Lu, David J Stewart, J Jack Lee, et al.
Acta Pharmacologica Sinica|June 11, 2025
Targeting PPARα activation sensitizes glioblastoma cells to temozolomide and reverses acquired resistance by inhibiting H3K18 lactylationZhen-Chuan Wang, Chen Li, Zhao Zhang, et al.
Oncotarget|December 15, 2015
Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cellsHongyu Li, Jing Hu, Shuhong Wu, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|May 8, 2008
Functional polymorphism of CYP2E1 gene and alcohol use disorders in a Tibetan populationWan-jun Guo, Gong-ga-lan-zi, Ou-zhu-luo-bu, et al.
Nature Communications|March 10, 2026
Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitisJennifer L Duffen, Kimberly K Crouse, Lin Ji, et al.
Pageof 37

Showing results (361-370 of 365) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 365 results.
Plos One|May 5, 2012
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humansCharles Lu, David J Stewart, J Jack Lee, et al.
Acta Pharmacologica Sinica|June 11, 2025
Targeting PPARα activation sensitizes glioblastoma cells to temozolomide and reverses acquired resistance by inhibiting H3K18 lactylationZhen-Chuan Wang, Chen Li, Zhao Zhang, et al.
Oncotarget|December 15, 2015
Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cellsHongyu Li, Jing Hu, Shuhong Wu, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|May 8, 2008
Functional polymorphism of CYP2E1 gene and alcohol use disorders in a Tibetan populationWan-jun Guo, Gong-ga-lan-zi, Ou-zhu-luo-bu, et al.
Nature Communications|March 10, 2026
Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitisJennifer L Duffen, Kimberly K Crouse, Lin Ji, et al.
Pageof 37